Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group LtdfiledCriticalGlaxo Group Ltd
Publication of UY33584ApublicationCriticalpatent/UY33584A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
La presente invención se refiere a nuevos compuestos que inhiben la actividad quinasa de LRRK2, a procedimientos para su preparación, a las composiciones que los contienen y a su uso en el tratamiento de enfermedades caracterizadas por la actividad quinasa de LRRK2, por ejemplo la enfermedad de Parkinson o la enfermedad de Alzheimer.The present invention relates to novel compounds that inhibit the kinase activity of LRRK2, to methods for its preparation, to compositions containing them and to their use in the treatment of diseases characterized by the kinase activity of LRRK2, for example Parkinson's disease or Alzheimer's disease.
UY0001033584A2010-09-022011-08-31
NEW BENZAMIDA COMPOUNDS OF LRRK2 INHIBITORS
UY33584A
(en)